Fidelity Investments
SGNT

Fidelity Investments’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Fidelity Investments’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-431,360
Closed -$6.46M – 2751
2016
Q2 		$6.46M Buy
431,360
+228,100
+112% +$2.93M ﹤0.01% 2125
2016
Q1 		$2.47M Sell
203,260
-25,600
-11% -$359K ﹤0.01% 2337
2015
Q4 		$3.64M Sell
228,860
-17,500
-7% -$276K ﹤0.01% 2292
2015
Q3 		$3.78M Buy
246,360
+10,600
+4% +$229K ﹤0.01% 2261
2015
Q2 		$5.73M Buy
235,760
+11,600
+5% +$278K ﹤0.01% 2197
2015
Q1 		$5.21M Sell
224,160
-252,200
-53% -$6.67M ﹤0.01% 2210
2014
Q4 		$12M Sell
476,360
-163,730
-26% -$4.8M ﹤0.01% 1940
2014
Q3 		$19.9M Sell
640,090
-66,330
-9% -$1.8M ﹤0.01% 1743
2014
Q2 		$18.3M Sell
706,420
-68,610
-9% -$1.52M ﹤0.01% 1833
2014
Q1 		$18.1M Buy
775,030
+513,030
+196% +$11.2M ﹤0.01% 1801
2013
Q4 		$6.65M Buy
+262,000
New +$5.92M ﹤0.01% 2091

Fidelity Investments's SGNT Position: Q3 2016 in Review

Fidelity Investments sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 431,360 shares — an estimated $6.46M sold.

Fidelity Investments first reported a position in SGNT in Q4 2013 and held it in 11 quarters. The position peaked at $19.9M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Fidelity Investments reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Fidelity Investments sold 431,360 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $6.46M.
  • Fidelity Investments first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 11 quarters.
  • Fidelity Investments's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $19.9M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Fidelity Investments's 13F filing for Q3 2016, filed 14 Nov 2016.